Skip to main content

. 1977 Mar;59(3):467P.

Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].

A C Dolphin, P Jenner, C D Marsden, M C Sawaya

PMCID: PMC1667979 PMID: 576587

467P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Corrodi H., Fuxe K., Hökfelt T., Lidbrink P., Ungerstedt U. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol. 1973 May;25(5):409–412. doi: 10.1111/j.2042-7158.1973.tb10037.x. [DOI] [PubMed] [Google Scholar]
Fuxe K., Corrodi H., Hökfelt T., Lidbrink P., Ungerstedt U. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med Biol. 1974 Apr;52(2):121–132. [PubMed] [Google Scholar]
Johnson A. M., Loew D. M., Vigouret J. M. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br J Pharmacol. 1976 Jan;56(1):59–68. doi: 10.1111/j.1476-5381.1976.tb06959.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

PDF (153.9 KB)

RESOURCES